Forwarding | Announcement of the Center for Drug Evaluation, National Medical Products Administration on the Publication of the "Technical Guidelines for the Scope and Classification of Cell Therapy D
2026/07/03
In order to standardize the scope and classification of cell therapy drugs, under the deployment of the National Medical Products Administration, the Drug Evaluation Center has organized the development of the "Technical Guidelines for the Scope and Classification of Cell Therapy Drugs (2026 Edition)" (see attachment). According to the Notice of the Comprehensive Department of the National Medical Products Administration on Issuing the Procedure for Issuing Drug Technical Guidance Principles (Drug Administration Comprehensive Drug Administration [2020] No. 9), and with the review and approval of the National Medical Products Administration, it is now issued and shall come into effect from the date of issuance.
This is to inform you.
This is to inform you.
National Medical Products Administration Drug Review Center
July 1, 2026
The article is sourced from the Drug Evaluation Center of the National Medical Products Administration. The original link is:
https://www.cde.org.cn/main/news/viewInfoCommon/56c7aff3a0301d6d96d5e58efd2bfd44
- Pre：Forwarding | New Edition of CNAS "Criteria for the Recognition of Inspection Agency Competence" to Take Effect from January 1, 2027
- Next：Forwarding | Notice on Soliciting Opinions on the Working Documents Related to the "Pilot Program for Advancing the Research and Application of New Approach Methods (NAMs) (Pioneer Program)"
